ONKI3 | Medical Subject Headings

The ONKI is provided as a part of the ONKI Living Lab - an open lab for testing the latest semantic web technologies in practice, with real users like you. Currently, over 10 000 people are using ONKI each month.

We hope you like the ONKI service and enjoy using it for your purposes!

If you encounter any problems or have improvement ideas, please contact the ONKI team. We are also very much interested in your success stories in using ONKI - please share your experiences!

The ONKI Team

Jouni Tuominen, Living Lab contact person, APIs, widgets, publishing of ontologies, etc.
Eero Hyvönen, professor, head of research group

Former members: Kim Viljanen, Rami Alatalo.

Building the future of the Semantic Web and beyond.

SeCo's homepage
For the latest semantic news, follow us on Twitter and fan us on Facebook!

How can we help you?

Live presentations about ONKI: what it is? how to use it?
Support for creating and publishing ontologies.
Online technical support for using ONKI.
Co-operation in projects.
And more, please ask.


Hierarchy:	Medical Subject Headings (MeSH) ∟ Heterocyclic Compounds ∟ Heterocyclic Compounds, 1-Ring ∟ Piperidines ∟ Mepivacaine 32 coordinate concepts ∟ Alphaprodine \| ∟ Anabasine \| ∟ Betalains \| ∟ Biperiden \| ∟ Cisapride \| ∟ Clopamide \| ∟ Cyproheptadine \| ∟ Domperidone \| ∟ Fentanyl \| ∟ Flecainide \| ∟ Fluspirilene \| ∟ Imino Pyranoses \| ∟ Indoramin \| ∟ Isonipecotic Acids \| ∟ Ketanserin \| ∟ Ketotifen \| ∟ Lobeline \| ∟ Loperamide \| ∟ Methylphenidate \| ∟ Minoxidil \| ∟ Nipecotic Acids \| ∟ Paroxetine \| ∟ Pempidine \| ∟ Penfluridol \| ∟ Perhexiline \| ∟ Phencyclidine \| ∟ Pipecolic Acids \| ∟ Piperidones \| ∟ Piperoxan \| ∟ Ritanserin \| ∟ Terfenadine \| ∟ Trihexyphenidyl X
Broader terms:	Medical Subject Headings (MeSH) ∟ Heterocyclic Compounds ∟ Heterocyclic Compounds, 1-Ring ∟ Piperidines ∟ Mepivacaine Piperidines > Heterocyclic Compounds, 1-Ring > Heterocyclic Compounds > Medical Subject Headings (MeSH) X
Scope note:	A local anesthetic that is chemically related to BUPIVACAINE but pharmacologically related to LIDOCAINE. It is indicated for infiltration, nerve block, and epidural anesthesia. Mepivacaine is effective topically only in large doses and therefore should not be used by this route. (From AMA Drug Evaluations, 1994, p168) X
activeMeSHYear*:	2006 \| 2007X
dateCreated*:	1999-01-01X
dateRevised*:	2005-06-30X
recordAuthorizer*:	sjnX
recordMaintainer*:	CCRX
recordOriginator*:	NLMX
Type:	Concept X
Coordinate terms:	Alphaprodine \| Anabasine \| Betalains \| Biperiden \| Cisapride \| Clopamide \| Cyproheptadine \| Domperidone \| Fentanyl \| Flecainide \| Fluspirilene \| Imino Pyranoses \| Indoramin \| Isonipecotic Acids \| Ketanserin \| Ketotifen \| Lobeline \| Loperamide \| Methylphenidate \| Minoxidil \| Nipecotic Acids \| Paroxetine \| Pempidine \| Penfluridol \| Perhexiline \| Phencyclidine \| Pipecolic Acids \| Piperidones \| Piperoxan \| Ritanserin \| Terfenadine \| Trihexyphenidyl X
URI:	X
Labels and equivalent concepts:	Mepivakaini (fi) Mepivakain (sv) Carbocain (sv, replaced) Polocaine (en, replaced) Pascoe Brand of Mepivacaine Hydrochloride (en, replaced) Novocol Brand of Mepivacaine Hydrochloride (en, replaced) Mepivacaine Monohydrochloride (en, replaced) Sanofi Brand of Mepivacaine Hydrochloride (en, replaced) Scandicain (en, replaced) Scandicaine (en, replaced) Inibsa Brand of Mepivacaine Hydrochloride (en, replaced) Hexal Brand of Mepivacaine Hydrochloride (en, replaced) Aventis Brand of Mepivacaine Hydrochloride (en, replaced) AstraZeneca Brand of Mepivacaine Hydrochloride (en, replaced) Astra Brand of Mepivacaine Hydrochloride (en, replaced) Abbott Brand of Mepivacaine Hydrochloride (en, replaced) Braun Brand of Mepivicaine Hydrochloride (en, replaced) Carbocaïne (en, replaced) Dentsply Brand of Mepivacaine Hydrochloride (en, replaced) curasan Brand of Mepivacaine Hydrochloride (en, replaced) Clarben Brand of Mepivacaine Hydrochloride (en, replaced) 3M Brand of Mepivacaine Hydrochloride (en, replaced) Mepivacainum (la-FI, replaced) X
Share:	X